MHC class I- and class II-restricted processing and presentation of microencapsulated antigens

By Men Y.   Audran R.   Thomasin C.   Eberl G.   Demotz S.   Merkle H.P.   Gander B.   Corradin G.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1047-1056

Elsevier

Access to resources Recommend Favorite

Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses

By Ridgely S.L.   McGuire T.C.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1809-1819

Elsevier

Access to resources Recommend Favorite

Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

By Herrera O.B.   Brett S.   Lechler R.I.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 231-242

Elsevier

Access to resources Recommend Favorite

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

By Hanke T.   Blanchard T.J.   Schneider J.   Hannan C.M.   Becker M.   Gilbert S.C.   Hill A.V.S.   Smith G.L.   McMichael A.  

Vaccine, Vol. 16, Iss. 5, 1998-03 ,pp. : 439-445

Elsevier

Access to resources Recommend Favorite

Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens

By Fu T.-M.   Guan L.   Friedman A.   Ulmer J.B.   Liu M.A.   Donnelly J.J.  

Vaccine, Vol. 16, Iss. 18, 1998-11 ,pp. : 1711-1717

Elsevier

Access to resources Recommend Favorite